Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Expert Opinion on Drug Safety|June 28, 2021
A review of hydroxyurea-related cutaneous adverse eventsMartin Griesshammer, Kai Wille, Parvis Sadjadian, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosisFrank Stegelmann, Max Bastian, Kay Swoboda, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2012
Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophagesHeiko Bruns, Frank Stegelmann, Mario Fabri, et al.Haematologica|December 18, 2009
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrationsFrank Stegelmann, Lars Bullinger, Martin Griesshammer, et al.Acta Haematologica|May 5, 2025
Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment: Results of the prospective PONS trialPhilipp le Coutre, Andreas Burchert, Susanne Saußele, et al.Blood|November 5, 2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsJoannah Score, Claire Hidalgo-Curtis, Amy V Jones, et al.Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.Acta Haematologica|October 17, 2023
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid LeukemiaSusanne Saussele, Paul La Rosée, Alexander Kiani, et al.Frontiers in Immunology|May 14, 2026
Impact of post-transplant cyclophosphamide and anti-thymocyte globulin on immune reconstitution in MUD allo-HCTGiulia Furnari, Verena Wais, Anna Francesio, et al.Pageof 4